Micro Cap Investors Are Looking At This Stock Making Waves In Its Rapidly Growing Market

Sponsored:

Tuesday, March 8, 2022

The world has seen some odd and challenging times in recent years. Those worried about the recent drop in stocks should consider a few things to keep the retreat in perspective because that’s where opportunities abound. We’ve gone through a “100-year pandemic” and are seeing the world start to bond in support of Ukraine two weeks after the Russian invasion, a war that has sent oil and select commodity (i.e., wheat, corn, palladium) prices skyrocketing while inflation balloons.

Still, we’re only about 9% from the Dow Jones’ record high set in January and roughly 14% above the Dow’s then record high in February 2020 just before the pandemic caused a market collapse (for which the Dow has gained 85% off the March 2020 low).

There’s always a bull market somewhere and apparently someone at Warren Buffett’s Berkshire Hathaway (NYSE: BRK.B) sees one in oil and Occidental Petroleum (NYSE: OXY). According to an SEC filing Friday, the investment giant has taken a $5.1 billion stake in Occidental, buying stock late last week at prices ranging from $47.07 to $56.45.

Those not looking to chase spiking oil prices may find opportunities in companies that have been diversifying for future growth and to provide extra cushion as the world returns to normalcy. If you ask Jamie Schau, Senior Insights Manager at Brightfield Group, the CBD industry will recapture momentum in 2022 after sluggishness in recent years owing to the coronavirus pandemic choking supply chains and closing retail stores.

Brightfield sees the U.S. CBD (cannabidiol) market growing from $5 billion in 2021 to $8 billion in 2022 and then $10 billion next year. More broadly, the Chicago-based analytics firm recently announced projections for the global hemp CBD industry to demonstrate 400% growth this year to $22 billion by the end of the year.

This market expansion bodes well for BioLife Sciences Inc. (OTCPK: BLFE), a Nevada-based upstart specialized in scaling small-scale operations to wider market adoption. Until recently, BioLife has mostly focused on its portfolio centered on its proprietary MFusion copper-infusion technology for products like air filters, facial masks, and a new fabric garden pot. Last month, the company added another pillar to its revenue model with the acquisition of Arizona-based orthomolecular medicine and natural health products company Health Box LLC.

Health Box offers a variety of supplements, super food concentrates, nutraceutical formulation, and advanced orthomolecular and natural health products founded on extensive research of medicinal botanicals, micronutrients, dietary supplements, proprietary herbal blends, and apothecary style subscription services.

The acquisition led to BioLife launching a new Life Sciences division and a subsector dedicated to developing innovative products from industrial hemp. Utilizing hemp, a fully legal, non-psychoactive cousin to marijuana that shares many cannabinoids except the psychoactive component THC, greatly eases the legal burden of product development for BioLife. The initial thrust will be on products using popular cannabinoids widely touted for potential medicinal benefits, such as CBD, CBG (cannabigerol) and CBN (cannabinol). Once criticized by conventional pharmas for a lack of clinical research, there is a growing body of evidence underscoring cannabinoids being lauded to help with a variant of diseases and conditions where traditional drugs have largely disappointed, such as in the areas of pain, anxiety, and depression.

BioLife intends to manufacture an array of novel consumer products that complement and expand the existing Health Box lineup while leveraging management’s expertise in micronutrients, botanicals, and holistic health care. These will include beverages, creams, salves, efficacious supplements, superfood concentrates, nutraceutical formulations, and advanced orthomolecular and natural health products.

“We believe CBD sales will continue their strong upward trend with current e-commerce sales soon being joined by consumers returning to brick and mortar options, as the pandemic wanes and disposable incomes continue to rise,” said Nika Jaksic, COO of BioLife Sciences. CBD and other cannabinoids found in the hemp plant are very helpful supplements, as evidenced by continuous studies highlighting that we haven’t even begun to understand all of these healing cannabinoid’s abilities and uses,” she concluded.

--

BioLife Sciences Inc. (OTCPK: BLFE) Full Corporate Write-Up: Click Here.

--

About AllPennyStocks.com:

AllPennyStocks.com Media, Inc., founded in 1999, is one of North America’s largest and most comprehensive small-cap / penny stock financial portals. With Canadian and U.S. focused penny stock features and content, the site offers information for novice investors to expert traders. Outside of the countless free content available to visitors, AllPennyStocks.com Pro (premium service) caters to traders looking for that trading edge by offering monthly stock picks, daily penny stock to watch trade ideas, market commentary and more.

As a result of its commitment to journalistic excellence and abundance of information in a particular area of equity investing (micro-cap investing) where there aren’t many credible sources of information, AllPennyStocks.com continues to have one of the largest audiences of micro-cap investors on the internet.

Sponsored: